Syngene CEO On sub-dynamics as US Biotech funding finds new normal, ADC capabilities: Scrip (citeline.com)
Syngene aims to optimise inventory, working capital cycle, says CFO
CRDMOs in India to create local supply eco-system, asserts itself as a bio-pharma sourcing powerhouse
Behind the numbers: How Syngene’s CFO is pioneering growth during sombre times
“3 Key Trends” with Mahesh Bhalgat
Biologics will be a major contributor to our growth, says Syngene CEO Jonathan Hunt
The landscape of STEM has significantly transformed
Innovative tumour models spearhead cancer research advancements
Fostering inclusion Empowering women in STEM
Power of AI to identify better drug targets and drug candidates
